Significant higher production of ROS was observed in lymphocytes and CD4+ T cells in RRMS patients at the relapse phase compared to patients at the remission phase and healthy individuals (P value < 0.02 and P value < 0.001, respectively) (Figures 3(a) and 3(b)). Here, CD4 is linked to relapsing-remitting multiple sclerosis.